{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-074978","form_type":"8-K","ticker":"HCIL","cik":"0001086303","company_name":"Hongchang International Co., Ltd","filed_at":"2023-09-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.110734+00:00","generated_at":"2026-06-10T22:32:26.451564+00:00","sec_items":["1.01","2.01","3.02","5.01","5.02","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"Heyu Biological Technology acquires Hongchang Group in reverse merger, exits prior cancer therapy business","bullets":["Acquired all shares of Hongchang BVI for 415.6M new shares (80.1% of post-acquisition total).","Disposed of prior business (HP TECHNOLOGY, Jiashierle, Kangzi) to director Ban Siong Ang for nominal consideration.","New business: Hongchang Food Industrial Park (under construction, completion expected 2024) in Fujian, China.","Mr. Zengqiang Lin becomes controlling shareholder via Zengqiang Investment Limited (415.6M shares).","Company now has 518.8M shares outstanding; new executive offices in Fuqing City, Fujian, China."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-074978","json":"https://secwatch.observer/filing/0001213900-23-074978.json","markdown":"https://secwatch.observer/filing/0001213900-23-074978.md","text":"https://secwatch.observer/filing/0001213900-23-074978.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1086303/000121390023074978/0001213900-23-074978-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1086303/000121390023074978/ea183857-8k_heyubiologi.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T22:32:26.451564+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1825fa74ff44e59632c3b4db7766232734373d58","claim":"Hongchang International Co., Ltd completed an acquisition involving Zengqiang Investment Limited and Hong Jin Investment Limited for 353,322,843 shares of our common stock to Zengqiang Investment Limited, and 62,259,532 shares of our common stock to Hong Jin Investment Limited (closed 2023-09-04).","evidence_excerpt":"In accordance with the terms of the Share Exchange Agreement, on September 4, 2023, the Selling Shareholders transferred 100 shares of Hongchang BVI, constituting one hundred percent (100%) of the issued and outstanding share capital of Hongchang BVI, to our Company in exchange for the issuance of 353,322,843 shares of our common stock to Zengqiang Investment Limited, and 62,259,532 shares of our common stock to Hong Jin Investment Limited.","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1086303/000121390023074978/0001213900-23-074978-index.htm","confidence":0.9,"family_label":"M&A Transactions","details":[{"label":"Action","value":"acquisition"},{"label":"Counterparty","value":"Zengqiang Investment Limited and Hong Jin Investment Limited"},{"label":"Consideration","value":"353,322,843 shares of our common stock to Zengqiang Investment Limited, and 62,259,532 shares of our common stock to Hong Jin Investment Limited"},{"label":"Closing","value":"2023-09-04"}],"fact_type":"ma_transaction"},{"claim_id":"771097908df32cf7615f9a0e4449adee2f377eb9","claim":"Hongchang International Co., Ltd completed a disposition involving Ban Siong Ang (closed 2023-09-04).","evidence_excerpt":"The Share Disposal was consummated on September 4, 2023.","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1086303/000121390023074978/0001213900-23-074978-index.htm","confidence":0.9,"family_label":"M&A Transactions","details":[{"label":"Action","value":"disposition"},{"label":"Counterparty","value":"Ban Siong Ang"},{"label":"Closing","value":"2023-09-04"}],"fact_type":"ma_transaction"},{"claim_id":"3fa04b32768483da01173adf4ac817d57141a261","claim":"Hongchang International Co., Ltd entered into Share Exchange Agreement with Zengqiang Investment Limited and Hong Jin Investment Limited valued at an aggregate of 415,582,375 new shares of our Company’s common stock (effective 2023-08-21).","evidence_excerpt":"On August 21, 2023, our Company entered into a Share Exchange Agreement (the “Share Exchange Agreement”) with Hongchang BVI, a business company incorporated in the BVI, and Hongchang BVI’s shareholders, Zengqiang Investment Limited, a business company incorporated in the BVI, and Hong Jin Investment Limited, a business company incorporated in the BVI (the “Selling Shareholders” and each a “Selling Shareholder”), in relation to the acquisition of Hongchang BVI by our Company (the “Hongchang Acquisition”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1086303/000121390023074978/0001213900-23-074978-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"merger"},{"label":"Counterparty","value":"Zengqiang Investment Limited and Hong Jin Investment Limited"},{"label":"Value","value":"an aggregate of 415,582,375 new shares of our Company’s common stock"},{"label":"Effective","value":"2023-08-21"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}